SARS-CoV-2 Humoral and Cellular Immune Responses of Patients With HIV After Vaccination With BNT162b2 mRNA COVID-19 Vaccine in the Tel-Aviv Medical Center

BACKGROUND: Little is known about vaccine efficacy and sustainability among people with HIV (PWH). We estimated humoral and cellular immune responses postvaccination with BNT162b2 mRNA coronavirus disease 2019 (COVID-19) vaccine among PWH in Tel-Aviv Medical Center. METHODS: The vaccine humoral resp...

Descripción completa

Detalles Bibliográficos
Autores principales: Tau, Luba, Turner, Dan, Adler, Amos, Marom, Rotem, Ahsanov, Svetlana, Matus, Natasha, Levi, Inbar, Gerber, Gal, Lev, Shir, Ziv-Baran, Tomer, Hagin, David, Freund, Tal, Grupper, Ayelet, Halperin, Tamar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962679/
https://www.ncbi.nlm.nih.gov/pubmed/35355894
http://dx.doi.org/10.1093/ofid/ofac089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962679/
https://www.ncbi.nlm.nih.gov/pubmed/35355894
http://dx.doi.org/10.1093/ofid/ofac089

Ejemplares similares